APP and Alzheimer disease: Importantly, HDAC6 seems to influence tau phosphorylation, autophagic flux, and tubulin acetylation [84], and its inhibition stimulates pathological tau degradation in ADLP APT mice (carrying six mutations in APP, PSEN1, and MAPT/tau) and AD patient-derived brain organoids [85].